Abstract:Listeria monocytogenes invades the cytoplasm of macrophages and induces the activation of caspase-1 and the subsequent maturation of IL-1 beta and IL-18. Although apoptosis-associated speck-like protein containing a caspase-activating and recruitment domain (ASC), an adaptor protein of nucleotide-binding oligomerization domain (Nod)-like receptors, has been shown to play an essential role in inducing this cellular response to L. monocytogenes, the mechanism has not been fully elucidated. In this study, we demonstrate the role of absent in melanoma 2 (AIM2), a recently described receptor of cytosolic DNA, in the activation of caspase-1 upon infection with L. monocytogenes. Secretion of IL-1 beta and IL-18 from Nod-like receptor family, pyrin domain containing 3 (NLRP3) and Nod-like receptor family, caspase-activating and recruitment domain containing 4 (NLRC4) knockout macrophages in response to L. monocytogenes was only slightly decreased compared with the levels secreted from wild-type macrophages, whereas secretion from ASC knockout macrophages was completely impaired, suggesting that receptors other than NLRP3 and NLRC4 also take part in inflammasome activation in an ASC-dependent manner. To identify such receptors, the abilities of several receptor candidates (NLRP2, NLRP6, NLRP12, and AIM2) to induce the secretion of IL-1 beta in response to L. monocytogenes were compared using the inflammasome system reconstructed in HEK293 cells. Among these receptor candidates, AIM2 conferred the highest responsiveness to the bacterium on HEK293 cells. Knockdown of AIM2 significantly decreased the secretion of IL-1 beta and IL-18 from L. monocytogenes-infected macrophages. These results suggest that AIM2, in cooperation with NLRP3 and NLRC4, plays an important role in the activation of caspase-1 during L. monocytogenes infection. The Journal of Immunology, 2010, 185: 1186-1195.

The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders

Emerging roles of absent in melanoma 2 in cardiovascular diseases

Absent in Melanoma 2 Mediates Inflammasome Signaling Activation against Clostridium perfringens Infection

The role of AIM2 in inflammation and tumors

Role of AIM2 inflammasome in inflammatory diseases, cancer and infection

Immunobiology and structural biology of AIM2 inflammasome

The complex role of AIM2 in autoimmune diseases and cancers

Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications

The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease

AIM2 Inflammasome: A Potential Therapeutic Target in Ischemic Stroke

Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications

Knockdown of the AIM2 molecule attenuates ischemia-reperfusion-induced spinal neuronal pyroptosis by inhibiting AIM2 inflammasome activation and subsequent release of cleaved caspase-1 and IL-1β

Absent in Melanoma 2 Inflammasome is Required for Host Defence Against Streptococcus Pneumoniae Infection.

Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly

Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes.

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

Activation and Pharmacological Regulation of Inflammasomes

The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases

Absent in melanoma 2 mediates aging‐related cognitive dysfunction by acting on complement‐dependent microglial phagocytosis

Activation and Regulation of Cellular Inflammasomes: Gaps in Our Knowledge for Central Nervous System Injury